Real world study of VMAT2 inhibitor valbenazine, deutetrabenazine, tetrabenazine in patients with Tardive Dyskinesia
Latest Information Update: 21 Oct 2020
At a glance
- Drugs Deutetrabenazine (Primary) ; Tetrabenazine (Primary) ; Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- 21 Oct 2020 New trial record
- 16 Sep 2020 Results presented at the 24th International Congress of Parkinson's Disease and Movement Disorders